The aim of this project is to strengthen the competitiveness and foster the innovation potential of Personalized Medicine as an Emerging Industry in Europe by providing key solutions for the reconfiguration of the biopharmaceutical value chain towards a Health Economy 4.0 with a special focus on oncology (i.e. cancer treatment). Current value chain challenges lie in e.g. data gathering and exchange, big data and machine learning, or new software-based marketing methods based.
Via a cross-clustering approach, leading biopharma and IT clusters from three countries (Austria, Germany and
Norway) will create novel cross-sectoral collaborations between SMEs to address innovation barriers in the biopharma sector via cutting-edge IT solutions. As a cross-cutting industry, the ICT and software sector is an enabler of innovation in many industries and therefore provides a broad knowledge base of processes and best practice solutions in diverse industrial contexts and business environments.
Partnerships to digitalize biopharmaceutical R&D
Advancing precision medicine in the digital age requires solutions developed in the IT and software sector, e.g. big data, machine learning, IT security, data protection, and cross-enterprise collaboration. The PERMIDES project aims at bringing together SMEs from the biopharmaceutical and IT sector to advance precision medicine through the development of novel digital solutions along the biopharmaceutical value chain. SMEs participating in the PERMIDES project can increase competitiveness and benefit from an innovation voucher scheme that will provide up to EUR 60,000 per project. About 90 innovation projects will be supported by the voucher scheme.